HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mark Bower Selected Research

Highly Active Antiretroviral Therapy (HAART)

11/2012HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
11/2012Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
6/2012Nonmelanoma skin cancers among HIV-infected persons in the HAART era.
4/2012Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
11/2011Colorectal cancer in HIV positive individuals: the immunological effects of treatment.
11/2010How I treat HIV-associated multicentric Castleman disease.
11/2010Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
3/2010Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
1/2010Primary esophageal carcinoma in the era of highly active antiretroviral therapy.
10/2009Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mark Bower Research Topics

Disease

26Acquired Immunodeficiency Syndrome (AIDS)
02/2013 - 02/2003
23Kaposi Sarcoma (Kaposi's Sarcoma)
02/2014 - 11/2002
19Neoplasms (Cancer)
01/2013 - 02/2003
17Infection
05/2015 - 02/2003
14Lymphoma (Lymphomas)
03/2014 - 03/2002
13HIV Infections (HIV Infection)
11/2013 - 02/2003
11Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2012 - 09/2003
8Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2014 - 09/2002
8Opportunistic Infections (Opportunistic Infection)
09/2012 - 03/2002
7Giant Lymph Node Hyperplasia (Castleman's Disease)
01/2014 - 09/2004
6Hodgkin Disease (Hodgkin's Disease)
02/2015 - 02/2008
4Burkitt Lymphoma (Burkitt's Lymphoma)
05/2015 - 04/2003
4Lung Neoplasms (Lung Cancer)
01/2013 - 02/2003
4B-Cell Lymphoma (Lymphoma, B Cell)
07/2011 - 08/2005
4Fever (Fevers)
11/2010 - 09/2005
3AIDS-Related Lymphoma (Lymphoma, AIDS Related)
03/2004 - 03/2002
2Lymphatic Diseases (Lymphadenopathy)
09/2008 - 06/2008
2Hepatitis B
09/2007 - 03/2004
2Anus Neoplasms (Anal Cancer)
02/2006 - 12/2004
2Neutropenia
09/2005 - 11/2004
1Diarrhea
05/2015
1Tumor Lysis Syndrome
05/2015
1Mucositis
05/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2014
1Immune Reconstitution Inflammatory Syndrome
06/2013
1Skin Neoplasms (Skin Cancer)
06/2012
1Colorectal Neoplasms (Colorectal Cancer)
11/2011
1Pneumonia (Pneumonitis)
06/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
02/2011
1Kidney Neoplasms (Kidney Cancer)
01/2011
1Epilepsy (Aura)
09/2010
1Partial Epilepsies (Epilepsy, Partial)
09/2010
1Seizures (Seizure)
09/2010
1Facial Pain (Myofacial Pain)
09/2010
1Carcinoma (Carcinomatosis)
01/2010
1Fibrosarcoma
01/2010
1Contagious Ecthyma (Orf)
01/2009
1Neoplasm Metastasis (Metastasis)
01/2009
1Choriocarcinoma
01/2009
1Testicular Neoplasms (Testicular Cancer)
01/2009
1Anemia
06/2008
1Hepatitis
03/2008
1Fibrosis (Cirrhosis)
03/2008
1Hepatocellular Carcinoma (Hepatoma)
03/2008
1Residual Neoplasm
03/2008

Drug/Important Bio-Agent (IBA)

6rituximab (Mabthera)FDA Link
05/2015 - 12/2007
6AntigensIBA
07/2011 - 04/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015 - 11/2004
4Multi-centric Castleman's DiseaseIBA
01/2014 - 06/2008
4RNA (Ribonucleic Acid)IBA
06/2013 - 03/2002
4DNA (Deoxyribonucleic Acid)IBA
06/2013 - 05/2003
4Protease Inhibitors (Protease Inhibitor)IBA
01/2011 - 07/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
05/2015 - 03/2006
3Vinblastine (Vinblastine Sulfate)FDA Link
02/2015 - 04/2012
3Bleomycin (Blenoxane)FDA LinkGeneric
02/2015 - 04/2012
3Dacarbazine (DIC)FDA LinkGeneric
02/2015 - 04/2012
3Monoclonal AntibodiesIBA
01/2014 - 09/2004
3Carbon MonoxideIBA
03/2008 - 06/2004
2Etoposide (VP 16)FDA LinkGeneric
05/2015 - 11/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2015 - 11/2004
2N-acetoacetyl-N-deacetylcolchicineIBA
01/2013 - 02/2009
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2004 - 02/2004
2CytokinesIBA
02/2004 - 02/2003
1Vincristine (Oncovin)FDA LinkGeneric
05/2015
1Prostate-Specific Antigen (Semenogelase)IBA
01/2014
1Deoxyglucose (2 Deoxy D glucose)IBA
04/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2011
1caspofungin (Cancidas)FDA Link
06/2011
1sunitinib (Sutent)FDA Link
01/2011
1C-Reactive ProteinIBA
11/2010
1Fluorouracil (Carac)FDA LinkGeneric
01/2010
1MafF Transcription FactorIBA
01/2010
1MicroRNAs (MicroRNA)IBA
01/2010
1Natural Killer Cell ReceptorsIBA
01/2009
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
01/2009
1Octreotide (Sandostatin)FDA LinkGeneric
01/2009
1Toll-Like Receptor 4IBA
11/2008
1SmokeIBA
09/2008
1pegylated liposomal doxorubicinIBA
06/2008
1Antidepressive Agents (Antidepressants)IBA
05/2008
1Pyridinolcarbamate (P23)IBA
05/2008
1Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2008
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
05/2008
1Cancer VaccinesIBA
03/2008

Therapy/Procedure

40Highly Active Antiretroviral Therapy (HAART)
11/2012 - 03/2002
23Drug Therapy (Chemotherapy)
05/2015 - 03/2002
6Transplants (Transplant)
11/2013 - 02/2003
4Art Therapy
06/2013 - 09/2007
2Immunotherapy
10/2009 - 04/2004
2Stem Cell Transplantation
10/2009 - 02/2008
2Combination Drug Therapy (Combination Chemotherapy)
03/2004 - 03/2002
2Chemoprevention
02/2004 - 04/2003
1Hematopoietic Stem Cell Mobilization
11/2013
1Aftercare (After-Treatment)
06/2011
1Microelectrodes
09/2010
1Homologous Transplantation (Allograft)
05/2010
1Radiotherapy
01/2010
1Radioimmunotherapy
10/2009
1Liver Transplantation
03/2008
1Retreatment
12/2007